Searchable abstracts of presentations at key conferences in endocrinology

ea0044p106 | Diabetes and Cardiovascular | SFEBES2016

Connexins, hemi-channels and ATP release in the diabetic kidney

Squires Paul E , Price Gareth W , Hills Claire E

Background: Changes in the expression of connexins have been linked to renal damage in diabetes and both hemi-channels and gap junctions represent potential therapeutic targets for the treatment of diabetic nephropathy. In the current study, we utilize model epithelial cells from human renal proximal tubules (HK2), to demonstrate a role for glucose and its downstream beta1 isoform of the pro-fibrotic cytokine transforming growth factor (TGFβ1) on connexin expression and h...

ea0032p440 | Diabetes | ECE2013

Ambulatory blood pressure profiles in type 2 diabetic patients

Nelaj E , Sadiku E , Gjata M , Tase M

Introduction: Arterial hypertension is a major risk factor for micro- and macrovascular complications in type 2 diabetes. Several factors are known to influence blood pressure profile in diabetic patients, such as age, sex, body weight, diabetes duration, insulin dosage, metabolic control, and microalbuminuria. Ambulatory blood pressure monitoring (ABPM) permits the observation of blood pressure throughout day and night. ABPM is better related to end organ damage and cardiovas...

ea0029oc4.3 | Pituitary Basic | ICEECE2012

miR-26a targets PRKCD in ACTH pituitary adenoma

Gentilin E. , Tagliati F. , degli Uberti E. , Zatelli M.

MicroRNAs (miRNAs) have several physiological functions, but have been also implicated in human neoplastic initiation and progression. We previously demonstrated that 30 miRNAs are differentially expressed in normal human pituitary as compared to pituitary adenomas. However, the most of miRNAs target genes remain unknown, hindering the understanding of the miRNAs contribute to pituitary tumorigenesis.The aims of this study were to: (i) validate a murine ...

ea0029p649 | Diabetes | ICEECE2012

Non-alcoholic fatty liver disease and cardiovascular disease in type 2 diabetic patients with metabolic syndrome

Nelaj E , Sadiku E , Gjata M , Tase M

Background: Type 2 diabetes is often associated with non-alcoholic fatty liver disease (NAFLD). Patients with NAFLD may be at greater risk for CVD than those without. The relationship between NAFLD and metabolic syndrome (MS) is very well recognized. The aim is to determine the association of NAFLD and the CVD between type 2 diabetic patients with and without MS.Materials and methods: One hundred and thirty type 2 diabetic patients (M: 71, F: 59, mean ag...

ea0029p1436 | Pituitary Clinical | ICEECE2012

Blast concussion is associated with high frequency of pituitary dysfunction

Wilkinson C. , Pagulayan K. , Colasurdo E. , Shofer J. , Peskind E.

Introduction: Studies of traumatic brain injury from all causes have found evidence of chronic hypopituitarism, defined by deficient production of one or more pituitary hormones at least 1 year after injury, in 25–50% of cases. Most studies found the occurrence of posttraumatic hypopituitarism (PTHP) to be unrelated to injury severity. Growth hormone deficiency (GHD) and hypogonadism were reported most frequently. Hypopituitarism, and in particular adult GHD, is associate...

ea0029p1507 | Pituitary Clinical | ICEECE2012

Glucose metabolism and lipid disturbances in acromegalic patients before and during treatment with long-acting somatostatin analogues

Kazmierczyk-Puchalska A , Andrysiak-Mamos E , Sowinska-Przepiera E , Syrenicz A

Introduction: Acromegaly causes hyperlipidemia and glucose metabolism disturbances what finally results in increased mortality. Correctin of those lipid and glucose disturbances during treatment with long-acting somatostatin analogues was examinated in this study.Material and methods: Eleven patients (9 women and 2 men) with active acromegaly and macroadenoma diagnosed at our Department in the years 2008–2011 underwent monitoring of lipids and gluco...

ea0029p1824 | Thyroid cancer | ICEECE2012

Iodine-131 lung uptake in bronchiectasis: a potential pitfall in the follow up of differentiated thyroid carcinoma (DTC)

Triggiani V. , Giagulli V. , Tafaro E. , Guastamacchia E.

DTC carries a good prognosis when adequately treated by means of total thyroidectomy, iodine-131 (I-131) treatment and TSH-suppressive therapy, and carefully followed up (i.e. serum thyroglobulin, I-131 total). In some cases, however, false-positive scans can occur. A 42-yr-old woman with recurrent chest infections and bronchiectasis was submitted to total thyroidectomy because of a13 mm nodule in the right lobe that showed a papillary thyroid carcinoma at FNAB histological ex...

ea0026p176 | Neuroendocrinology | ECE2011

Hypothalamic neuropeptide Y controls the hepatic secretion of VLDL triglycerides in rats via the sympathetic nervous system

Bruinstroop E , Pei L , Ackermans M , Fliers E , Kalsbeek A

During fasting neuropeptide Y (NPY) neurons in the mediobasal hypothalamus are activated to increase food intake and to conserve energy. Under conditions of food deprivation, lipid metabolism plays an important role in providing fuel for muscle. We investigated if central NPY affects VLDL-TAG secretion directly via the autonomic nervous system. We measured VLDL-TAG secretion in Wistar rats by an intravenous bolus of tyloxapol to inhibit uptake of triglycerides by peripheral ti...

ea0026p228 | Pituitary | ECE2011

Non-traditional effects of GH: a survival factor for retinal ganglion cells

Harvey S , Lin W , Parker E , Sanders E

Introduction: GH and its receptor (GHR) are expressed in retinal ganglion cells (RGCs) in the eyes of chick embryos, and in mouse, rat and human eyes. Within the retina, exogenous GH has neuroprotective actions, mediated by caspase-dependent and caspase-independent mechanisms that may also be dependent upon IGF1 signaling. Conversely, the immunoneutralization of endogenous GH promotes apoptosis in the retina and in isolated RCGs. The functional relevance of retinal GH was furt...

ea0026p300 | Pituitary | ECE2011

Secondary erythrocytosis due to acromegaly

Pigarova E , Dobracheva E , Dzeranova L , Rozhinskaya L

A 53-year-old man with acromegaly was referred for neurosurgical treatment. At admission: GH 240 ME/l at all time points of glucose tolerance test, IGF1 – 415.1 ng/ml, brain MRI showed pituitary adenoma 34×32×27 mm extending suprasellar, deforming and displacing optic chiasm, parasellar to both cavernous sinuses and surrounding left internal carotid artery. Clinical blood tests revealed marked erythrocytosis – 6.1×1012, Hb – 200 g/l, HC...